ConductScience.org, home

Trial · NCT00683124

Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients

NCT00683124, Phase 3, Unknown, Fondazione IRCCS Policlinico San Matteo di Pavia

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients. Trials, record NCT00683124. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00683124

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients
NCT number
NCT00683124
Status
Unknown
Phases
Phase 3
Enrollment
291 participants, estimated
Lead sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions
Marfan Syndrome
Interventions
Losartan and nebivolol, Losartan, Nebivolol
First posted
2008-05-23
Last updated
2011-07-22
Other registries' IDs
eudract:2008-001462-81

Source ClinicalTrials.gov

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryBSA and age-adjusted aortic root diameter (sinuses of Valsalva)every 12 months
SecondaryThe pharmacokinetics of the two drugs by age and dosagesevery 12 months
SecondaryComparative evaluation of the serum levels of total and active TGFbevery 12 months
SecondaryQuantitative assessment of the expression of the mutated gene (FBN1, both 5' and 3')every 12 months
SecondaryPharmacogenetic bases of drug responsiveness (Losartan: CYP2C9 gene) (Nebivolol: CYP2D6 gene)every 12 months
SecondaryAortic valve regurgitation severityevery 12 months
SecondaryLeft ventricular end-diastolic diameterevery 12 months
SecondaryLeft ventricular ejection fractionevery 12 months
SecondarySpirometric lung volumes and flowsevery 12 months
SecondaryQoL evaluation basing on SF-36 questionnaireevery 12 months

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers15

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
1593914BACKGROUNDPubMed
2462161BACKGROUNDPubMed
2773795BACKGROUNDPubMed
9150447BACKGROUNDPubMed
9453300BACKGROUNDPubMed
9990650BACKGROUNDPubMed
11087260BACKGROUNDPubMed
11171784BACKGROUNDPubMed
15262912BACKGROUNDPubMed
15587107BACKGROUNDPubMed

1 to 10 of 15

See all 15 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00683124

GET https://conductscience.org/api/trials/v1/NCT00683124/registered